Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Narrden, Netherlands
SEC filing record 1 source field available
Fiscal year end
31 December
NewAmsterdam Pharma Co N.V. has filed 412 SEC EDGAR filings since 04 Aug 2022

SEC filing history

Showing 401-412 of 412 matching filings.

Per page
25
Current page
17
425

425

Filing date
24 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
23 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
19 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
17 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
16 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 333-266510

425

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
09 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
08 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
425

425

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
F-4 File 333-266510

FORM F-4

Filing date
04 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .